: Him & Hers raises full-year sales outlook, but stock falls


Hims & Hers Health Inc. HIMS — the wellness company behind the online telehealth and prescription platforms Hims and Hers — on Monday reported a bigger per-share loss than expected for its first quarter, but raised its full-year sales forecast. The company — which offers erectile dysfunction pills, birth control, and anxiety and depression medications — said it expected full-year sales of $810 million to $830 million, compared with an earlier outlook for $735 million to $755 million and FactSet forecasts for $755.3 million. For its first quarter, the company reported a net loss of $10.1 million, or 5 cents a share, compared…

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleDow Jones Newswires: China’s export growth slows in April
Next articleDow Jones Newswires: UBS outlines new leadership team as it says Credit Suisse deal will close in coming weeks


Please enter your comment!
Please enter your name here